PHARMA FIDELMED
The computed 12-month bankruptcy probability of PHARMA FIDELMED is 2.7% (moderate). The 2024 annual accounts show negative equity (€-427k) and a net result of €-38k. Equity is shrinking by ~37.7% per year across the filed fiscal years. Its solvency ranks better than 9% of 1230 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-427k |
| Net result | €-38k |
| Staff (FTE) | 2.2 |
| Better than sector | 9% |
Mixed profile: strong on stability, weaker on health.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -25.1% | 20.3% | |
| Net result | €-38k | €25k | |
| Equity | €-427k | €142k | |
| Gross operating margin | €363k | €215k | |
| Staff costs | €152k | €160k |
Show 11 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €211k |
| Net profit | €-38k |
| Cash flow | €149k |
| Staff costs | €152k |
| Income taxes | €250 |
| Dividends | - |
| Total assets | €1.70M |
| Equity | €-427k |
| Debt | €2.13M |
| of which ≤ 1y | €1.29M |
| of which > 1y | €834k |
| Working capital | €-709k |
| Employees (FTE) | 2.2 |
| 2024 | |
|---|---|
| Current ratio | 0.45 |
| Quick ratio | 0.45 |
| Working capital ratio | -41.7% |
| Solvency | -25.1% |
| Debt / equity | -4.98 |
| Long-term debt ratio | -1.95 |
| Interest coverage | 3.40 |
| Gross margin | - |
| Net margin | - |
| ROA | -2.2% |
| ROE | 8.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.70M |
| Fixed assets | 21/28 | €1.12M |
| Intangible fixed assets | 21 | €92k |
| Tangible fixed assets | 22/27 | €1.02M |
| Current assets | 29/58 | €585k |
| Stocks & contracts in progress | 3 | €743 |
| Amounts receivable within one year | 40/41 | €561k |
| Cash & bank | 54/58 | €22k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.70M |
| Equity | 10/15 | €-427k |
| Contributions / capital | 10/11 | €20k |
| Accumulated profits (losses) | 14 | €-447k |
| Amounts payable | 17/49 | €2.13M |
| Amounts payable after one year | 17 | €834k |
| Amounts payable within one year | 42/48 | €1.29M |
| Trade debts payable within one year | 44 | €112k |
| Income statement | ||
| Gross operating margin | 9900 | €363k |
| Operating result | 9901 | €24k |
| Financial income | 75 | €41 |
| Financial charges | 65 | €62k |
| Result before taxes | 9903 | €-38k |
| Income taxes | 67/77 | €250 |
| Net result for the period | 9904 | €-38k |
| Result to be appropriated | 9905 | €-38k |
-
Current07-02-2025 → present
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 26-01-2021 |
| Status | Active |
| Postal code | 9030 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44038A0046/00C002 | Flanders | 9,704 m² | 1 · 2,861 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
09-05-2025 2 directors appointed
- mediaxe BV, Bestuurder
- Jos Aelbrecht, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "mediaxe BV",
"address": "9300 Aalst, Afspanningsstraat 35",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": {
"kbo": "0811.991.552",
"name": "mediaxe BV",
"address": "9300 Aalst, Afspanningsstraat 35",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": false,
"effective_date": "2025-02-07",
"evidence_quote": "De enige aandeelhouder, optredend in haar hoedanigheid van algemene vergadering van voormelde vennootschap, neemt volgende beslissingen.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jos Aelbrecht",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": "0468.055.484",
"name": "Baker Tilly Accountants \u0026 Belastingadviseurs BV",
"address": "9300 Aalst, Kareelstraat 122",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering beslist om bijzondere volmacht te verlenen aan Baker Tilly Accountants \u0026 Belastingadviseurs BV, met zetel te 9300 Aalst, Kareelstraat 122, 0468.055.484 RPR Gent afdeling Dendermonde, vertegenwoordigd door Jos Aelbrecht, gedelegeerd bestuurder, voor de ondertekening en neerlegging van ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-05-09",
"filing_date": "2025-04-30",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-02-12",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0762.489.086",
"name_full": "PHARMA FIDELMED",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}19-10-2023 Registered office moved within Mariakerke
- Waalkens 11b, 9030 Mariakerke (Gent), België → Waalkens 11C te Mariakerke
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Waalkens 11C te Mariakerke",
"city": "Mariakerke",
"region": null,
"street": "Waalkens",
"country": "BE",
"postcode": null,
"box_number": null,
"street_number": "11C",
"locality_suffix": null
},
"old_address": {
"raw": "Waalkens 11b, 9030 Mariakerke (Gent), Belgi\u00EB",
"city": "Mariakerke",
"region": "vlaams_gewest",
"street": "Waalkens",
"country": "BE",
"postcode": "9030",
"box_number": null,
"street_number": "11B",
"locality_suffix": "(Gent)"
},
"effective_date": "2023-08-29",
"evidence_quote": "",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2023-10-10",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enige_bestuurder",
"date": null,
"unanimous": null
},
"subject_company": {
"kbo": "0762.489.086",
"name_full": "Pharma Fidelmed",
"legal_form": "BV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Andy Decuypere",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": [
"Bijlagen bij het-Be\u0142gisch Staatsblad--19/10/2023~-Annexes du Moniteur-belge-"
]
}| Legal nameNL | PHARMA FIDELMED |